Regulatory

This expansion of the Stratum brand will result in close to 70 options to treat deformities and fractures in the human foot.

The JuniOrtho system is now FDA 510(k) cleared and has CE Mark approval supporting advanced deformity and trauma reconstruction of the lower extremities in pediatric patients.

S-Core Core-preserving Osteochondral Reconstruction and Joint Repair Platform Technology addresses the fundamental issue of joint damage.

The DuoHex CH System addresses hammertoe deformity and provides surgeons with a novel two-piece threaded implant construct.

The new indication expansion significantly broadens the Photodynamic Bone Stabilization System to address the geriatric fragility fracture market.

The continued expansion of Nextremity Solutions' portfolio addresses additional complications in the foot.

Gramercy Extremity Orthopedics was granted FDA 510(k) clearance for the GEO FirstFuse MTPJ Fusion Plate.

OSSIO was granted FDA 510(k) clearance to market the OSSIOfiber® Hammertoe Fixation system.

Paragon 28 was granted FDA 510(k) clearance to market the Phantom® ActivCore Nail.

Silver Bullet Therapeutics received CE Mark approval for the OrthoFuzIon™ Bone Screw for reduction and internal fixation procedures anywhere in the body.